Clinical Trial: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Chronic Kidney Diseases
Study Type: INTERVENTIONAL
Official Title: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Brief Summary:
The goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung function and circulating metabolites (substances created when our bodies break down food, drugs, or its own tissues) in patients with chronic kidney disease.
Read more